![Chunghwa Chemical Synthesis & Biotech Co., Ltd. logo](/logos/1762.TW.webp)
Chunghwa Chemical Synthesis & Biotech Co., Ltd.
TWSE:1762.TW
Overview | Financials
Company Name | Chunghwa Chemical Synthesis & Biotech Co., Ltd. |
Symbol | 1762.TW |
Currency | TWD |
Price | 41.55 |
Market Cap | 3,222,618,000 |
Dividend Yield | 2.82% |
52-week-range | 40.7 - 63.1 |
Industry | Biotechnology |
Sector | Healthcare |
CEO | Mr. Chung-Hsin Huang |
Website | https://www.ccsb.com.tw |
An error occurred while fetching data.
About Chunghwa Chemical Synthesis & Biotech Co., Ltd.
Chunghwa Chemical Synthesis & Biotech Co., Ltd. engages in the research, development, manufacture, and wholesale of active pharmaceutical ingredients (APIs) in Taiwan and the United States. It offers API products, which include immunosuppressant, oncology, cardiovascular, and other products, as well as peptide drugs. The company also develops bulk pharmaceutical products,
Related Stocks
Financials
Numbers are in millions USD
Numbers are in millions USD